GCM Grosvenor Holdings’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-495,916
| Closed | -$1.74M | – | 21 |
|
|
2024
Q3 | $1.74M | Hold |
495,916
| – | – | 0.26% | 20 |
|
|
2024
Q2 | $1.63M | Hold |
495,916
| – | – | 0.24% | 19 |
|
|
2024
Q1 | $3.64M | Hold |
495,916
| – | – | 0.56% | 18 |
|
|
2023
Q4 | $1.85M | Hold |
495,916
| – | – | 0.33% | 17 |
|
|
2023
Q3 | $1.05M | Hold |
495,916
| – | – | 0.21% | 14 |
|
|
2023
Q2 | $2.36M | Hold |
495,916
| – | – | 1.02% | 12 |
|
|
2023
Q1 | $2.83M | Sell |
495,916
-541,340
| -52% | -$3.09M | 0.76% | 12 |
|
|
2022
Q4 | $10.5M | Hold |
1,037,256
| – | – | 2.67% | 11 |
|
|
2022
Q3 | $23.2M | Hold |
1,037,256
| – | – | 5.51% | 8 |
|
|
2022
Q2 | $25.7M | Buy |
+1,037,256
| New | +$25.7M | 5.81% | 8 |
|